Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Warts × Maltose × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Warts 1 Papilloma 1 Neoplasms 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1

Interventions

resiquimod 5 VP-102 2 N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2 Cantharidin 2 2-Propanol 2 methyl 5-aminolevulinate 1 ammonium trichloro(dioxoethylene-O,O'-)tellurate 1 Sugars 1 Photochemotherapy 1 Nitric Oxide 1 Maltose 1 Interferon-alpha 1 Imiquimod 1 Exercise 1 Cryotherapy 1 3-ingenyl angelate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00454181 2011-09-16

Treatment of Oral Warts in HIV+ Patients

Ainos, Inc. (f/k/a Amarillo Biosciences Inc.

Phase 2 Completed

59 enrolled 13 charts

Acquired Immunodeficiency Syndrome, Papilloma, Warts, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡